FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4223889788> ?p ?o ?g. }

• W4223889788 abstract "Abstract Background Otitis media with effusion (OME) is common and occurs at disproportionately higher rates among Indigenous children. Left untreated, OME can negatively affect language, development, learning, and health and wellbeing throughout the life-course. Currently, OME care includes observation for 3 months followed by consideration of surgical ventilation tube insertion. The use of a non-invasive, low-cost nasal balloon autoinflation device has been found beneficial in other populations but has not been investigated among Aboriginal and Torres Strait Islander children. Methods/design This multi-centre, open-label, randomised controlled trial will determine the effectiveness of nasal balloon autoinflation compared to no nasal balloon autoinflation, for the treatment of OME among Aboriginal and Torres Strait Islander children in Australia. Children aged 3–16 years with unilateral or bilateral OME are being recruited from Aboriginal Health Services and the community. The primary outcome is the proportion of children showing tympanometric improvement of OME at 1 month. Improvement is defined as a change from bilateral type B tympanograms to at least one type A or C1 tympanogram, or from unilateral type B tympanogram to type A or C1 tympanogram in the index ear, without deterioration (type A or C1 to type C2, C3, or B tympanogram) in the contralateral ear. A sample size of 340 children (170 in each group) at 1 month will detect an absolute difference of 15% between groups with 80% power at 5% significance. Anticipating a 15% loss to follow-up, 400 children will be randomised. The primary analysis will be by intention to treat. Secondary outcomes include tympanometric changes at 3 and 6 months, hearing at 3 months, ear health-related quality of life (OMQ-14), and cost-effectiveness. A process evaluation including perspectives of parents or carers, health care providers, and researchers on trial implementation will also be undertaken. Discussion INFLATE will answer the important clinical question of whether nasal balloon autoinflation is an effective and acceptable treatment for Aboriginal and Torres Strait Islander children with OME. INFLATE will help fill the evidence gap for safe, low-cost, accessible OME therapies. Trial registration Australia New Zealand Clinical Trials Registry ACTRN12617001652369 . Registered on 22 December 2017. The Australia New Zealand Clinical Trials Registry is a primary registry of the WHO ICTRP network and includes all items from the WHO Trial Registration data set. Retrospective registration." @default.
• W4223889788 created "2022-04-19" @default.
• W4223889788 creator A5012760511 @default.
• W4223889788 creator A5014393409 @default.
• W4223889788 creator A5015335788 @default.
• W4223889788 creator A5024313361 @default.
• W4223889788 creator A5024489438 @default.
• W4223889788 creator A5035441685 @default.
• W4223889788 creator A5037391538 @default.
• W4223889788 creator A5038359795 @default.
• W4223889788 creator A5038732185 @default.
• W4223889788 creator A5041447887 @default.
• W4223889788 creator A5051815551 @default.
• W4223889788 creator A5061452260 @default.
• W4223889788 creator A5061884440 @default.
• W4223889788 creator A5071218634 @default.
• W4223889788 creator A5076210501 @default.
• W4223889788 creator A5077012475 @default.
• W4223889788 creator A5082791453 @default.
• W4223889788 creator A5085231449 @default.
• W4223889788 creator A5089991211 @default.
• W4223889788 date "2022-04-14" @default.
• W4223889788 modified "2023-10-06" @default.
• W4223889788 title "INFLATE: a protocol for a randomised controlled trial comparing nasal balloon autoinflation to no nasal balloon autoinflation for otitis media with effusion in Aboriginal and Torres Strait Islander children" @default.
• W4223889788 cites W180230778 @default.
• W4223889788 cites W1935115161 @default.
• W4223889788 cites W1976770755 @default.
• W4223889788 cites W2021159372 @default.
• W4223889788 cites W2022290180 @default.
• W4223889788 cites W2022966386 @default.
• W4223889788 cites W2027650661 @default.
• W4223889788 cites W2062560376 @default.
• W4223889788 cites W2065673455 @default.
• W4223889788 cites W2082538594 @default.
• W4223889788 cites W2105967092 @default.
• W4223889788 cites W2108926754 @default.
• W4223889788 cites W2111872583 @default.
• W4223889788 cites W2122185155 @default.
• W4223889788 cites W2135243304 @default.
• W4223889788 cites W2141346035 @default.
• W4223889788 cites W2144771100 @default.
• W4223889788 cites W2150500774 @default.
• W4223889788 cites W2163385534 @default.
• W4223889788 cites W2166023752 @default.
• W4223889788 cites W2218096687 @default.
• W4223889788 cites W2250918035 @default.
• W4223889788 cites W2292659054 @default.
• W4223889788 cites W2358425299 @default.
• W4223889788 cites W2413282463 @default.
• W4223889788 cites W2605667004 @default.
• W4223889788 cites W2772803673 @default.
• W4223889788 cites W2886150863 @default.
• W4223889788 cites W2887222479 @default.
• W4223889788 cites W2940683832 @default.
• W4223889788 cites W2992614 @default.
• W4223889788 cites W3015003592 @default.
• W4223889788 cites W3045621668 @default.
• W4223889788 cites W4254906800 @default.
• W4223889788 doi "https://doi.org/10.1186/s13063-022-06145-8" @default.
• W4223889788 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35421984" @default.
• W4223889788 hasPublicationYear "2022" @default.
• W4223889788 type Work @default.
• W4223889788 citedByCount "2" @default.
• W4223889788 countsByYear W42238897882022 @default.
• W4223889788 countsByYear W42238897882023 @default.
• W4223889788 crossrefType "journal-article" @default.
• W4223889788 hasAuthorship W4223889788A5012760511 @default.
• W4223889788 hasAuthorship W4223889788A5014393409 @default.
• W4223889788 hasAuthorship W4223889788A5015335788 @default.
• W4223889788 hasAuthorship W4223889788A5024313361 @default.
• W4223889788 hasAuthorship W4223889788A5024489438 @default.
• W4223889788 hasAuthorship W4223889788A5035441685 @default.
• W4223889788 hasAuthorship W4223889788A5037391538 @default.
• W4223889788 hasAuthorship W4223889788A5038359795 @default.
• W4223889788 hasAuthorship W4223889788A5038732185 @default.
• W4223889788 hasAuthorship W4223889788A5041447887 @default.
• W4223889788 hasAuthorship W4223889788A5051815551 @default.
• W4223889788 hasAuthorship W4223889788A5061452260 @default.
• W4223889788 hasAuthorship W4223889788A5061884440 @default.
• W4223889788 hasAuthorship W4223889788A5071218634 @default.
• W4223889788 hasAuthorship W4223889788A5076210501 @default.
• W4223889788 hasAuthorship W4223889788A5077012475 @default.
• W4223889788 hasAuthorship W4223889788A5082791453 @default.
• W4223889788 hasAuthorship W4223889788A5085231449 @default.
• W4223889788 hasAuthorship W4223889788A5089991211 @default.
• W4223889788 hasBestOaLocation W42238897881 @default.
• W4223889788 hasConcept C141071460 @default.
• W4223889788 hasConcept C168563851 @default.
• W4223889788 hasConcept C187212893 @default.
• W4223889788 hasConcept C2776439223 @default.
• W4223889788 hasConcept C548259974 @default.
• W4223889788 hasConcept C71924100 @default.
• W4223889788 hasConceptScore W4223889788C141071460 @default.
• W4223889788 hasConceptScore W4223889788C168563851 @default.
• W4223889788 hasConceptScore W4223889788C187212893 @default.
• W4223889788 hasConceptScore W4223889788C2776439223 @default.
• W4223889788 hasConceptScore W4223889788C548259974 @default.
• W4223889788 hasConceptScore W4223889788C71924100 @default.
• W4223889788 hasFunder F4320334705 @default.
• W4223889788 hasIssue "1" @default.

• next